Hello and nice to see you again. Having successfully deposited one of the short people at the local schoolhouse, we are celebrating with yet another cup of stimulation. Please join us or grab a bottle of water, if you prefer, and get ready for another day of meetings and deadlines and who-knows-what-else. Meanwhile, here are some fresh tidbits. Have a good one and stay in touch...
China To Help Domestic Drugmakers Expand Overseas (Global Times)
AstraZeneca Pays $150M To Settle More Seroquel Lawsuits (Bloomberg News)
Amgen Haunted By Medicare Worries (Forbes)
Glaxo Cuts Neuroscience Jobs In North Carolina (MedCity News)
UK's NICE Endorses Celgene Blood Cancer Med (Reuters)
Allergan Wins Wider Use For Lap-Band Device (Wall Street Journal)
EU Parliament Approves Tougher Counterfeit Laws (Pharma Times)
Astellas To Pay Up To $1.3B To Aveo For Cancer Drug (Bloomberg News)
Roche's Avastin Shows Promise For Newborn Blindness (Reuters)
Canadian Clinical Trial Patient Info Is Vulnerable (Outsourcing Pharma)
European Drugmakes Criticize Obama Patent Proposal (Wall Street Journal)
Lilly Touts Its R&D Programs (Pharma Times)
Amgen Eyes Pfizer Plant In Dublin (Irish Times)
2 Comments
This headline writer needs to retake grammar 101.
GSK layoffs hit US neuroscience staff; half of less than 50 jobs lost from RTP
Hi Industry Insider,
Thanks for the note and the observation. And so the headline has been tweaked to more accurately reflect the content reported in the story. Appreciate that you pointed it out.
Regards ed